1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global HIV Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) 1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) 1.2.4 Entry and Fusion Inhibitors 1.2.5 Protease Inhibitors (PIs) 1.2.6 Integrase Inhibitors 1.2.7 Coreceptor Antagonists 1.3 Market by Application 1.3.1 Global HIV Therapeutics Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Labs 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global HIV Therapeutics Market Perspective (2017-2028) 2.2 HIV Therapeutics Growth Trends by Region 2.2.1 HIV Therapeutics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 HIV Therapeutics Historic Market Size by Region (2017-2022) 2.2.3 HIV Therapeutics Forecasted Market Size by Region (2023-2028) 2.3 HIV Therapeutics Market Dynamics 2.3.1 HIV Therapeutics Industry Trends 2.3.2 HIV Therapeutics Market Drivers 2.3.3 HIV Therapeutics Market Challenges 2.3.4 HIV Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top HIV Therapeutics Players by Revenue 3.1.1 Global Top HIV Therapeutics Players by Revenue (2017-2022) 3.1.2 Global HIV Therapeutics Revenue Market Share by Players (2017-2022) 3.2 Global HIV Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by HIV Therapeutics Revenue 3.4 Global HIV Therapeutics Market Concentration Ratio 3.4.1 Global HIV Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by HIV Therapeutics Revenue in 2021 3.5 HIV Therapeutics Key Players Head office and Area Served 3.6 Key Players HIV Therapeutics Product Solution and Service 3.7 Date of Enter into HIV Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 HIV Therapeutics Breakdown Data by Type 4.1 Global HIV Therapeutics Historic Market Size by Type (2017-2022) 4.2 Global HIV Therapeutics Forecasted Market Size by Type (2023-2028) 5 HIV Therapeutics Breakdown Data by Application 5.1 Global HIV Therapeutics Historic Market Size by Application (2017-2022) 5.2 Global HIV Therapeutics Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America HIV Therapeutics Market Size (2017-2028) 6.2 North America HIV Therapeutics Market Size by Country (2017-2022) 6.3 North America HIV Therapeutics Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe HIV Therapeutics Market Size (2017-2028) 7.2 Europe HIV Therapeutics Market Size by Country (2017-2022) 7.3 Europe HIV Therapeutics Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific HIV Therapeutics Market Size (2017-2028) 8.2 Asia-Pacific HIV Therapeutics Market Size by Country (2017-2022) 8.3 Asia-Pacific HIV Therapeutics Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America HIV Therapeutics Market Size (2017-2028) 9.2 Latin America HIV Therapeutics Market Size by Country (2017-2022) 9.3 Latin America HIV Therapeutics Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa HIV Therapeutics Market Size (2017-2028) 10.2 Middle East & Africa HIV Therapeutics Market Size by Country (2017-2022) 10.3 Middle East & Africa HIV Therapeutics Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Boehringer Ingelheim International GmbH 11.1.1 Boehringer Ingelheim International GmbH Company Detail 11.1.2 Boehringer Ingelheim International GmbH Business Overview 11.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Introduction 11.1.4 Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2017-2022) 11.1.5 Boehringer Ingelheim International GmbH Recent Development 11.2 Merck & Co. 11.2.1 Merck & Co. Company Detail 11.2.2 Merck & Co. Business Overview 11.2.3 Merck & Co. HIV Therapeutics Introduction 11.2.4 Merck & Co. Revenue in HIV Therapeutics Business (2017-2022) 11.2.5 Merck & Co. Recent Development 11.3 ViiV Healthcare 11.3.1 ViiV Healthcare Company Detail 11.3.2 ViiV Healthcare Business Overview 11.3.3 ViiV Healthcare HIV Therapeutics Introduction 11.3.4 ViiV Healthcare Revenue in HIV Therapeutics Business (2017-2022) 11.3.5 ViiV Healthcare Recent Development 11.4 AbbVie 11.4.1 AbbVie Company Detail 11.4.2 AbbVie Business Overview 11.4.3 AbbVie HIV Therapeutics Introduction 11.4.4 AbbVie Revenue in HIV Therapeutics Business (2017-2022) 11.4.5 AbbVie Recent Development 11.5 F. Hoffmann-La Roche Ltd. 11.5.1 F. Hoffmann-La Roche Ltd. Company Detail 11.5.2 F. Hoffmann-La Roche Ltd. Business Overview 11.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Introduction 11.5.4 F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2017-2022) 11.5.5 F. Hoffmann-La Roche Ltd. Recent Development 11.6 Teva Pharmaceutical Industries Ltd. 11.6.1 Teva Pharmaceutical Industries Ltd. Company Detail 11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview 11.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Introduction 11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2017-2022) 11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development 11.7 Bristol-Myers Squibb 11.7.1 Bristol-Myers Squibb Company Detail 11.7.2 Bristol-Myers Squibb Business Overview 11.7.3 Bristol-Myers Squibb HIV Therapeutics Introduction 11.7.4 Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2017-2022) 11.7.5 Bristol-Myers Squibb Recent Development 11.8 Gilead Sciences 11.8.1 Gilead Sciences Company Detail 11.8.2 Gilead Sciences Business Overview 11.8.3 Gilead Sciences HIV Therapeutics Introduction 11.8.4 Gilead Sciences Revenue in HIV Therapeutics Business (2017-2022) 11.8.5 Gilead Sciences Recent Development 11.9 Johnson & Johnson 11.9.1 Johnson & Johnson Company Detail 11.9.2 Johnson & Johnson Business Overview 11.9.3 Johnson & Johnson HIV Therapeutics Introduction 11.9.4 Johnson & Johnson Revenue in HIV Therapeutics Business (2017-2022) 11.9.5 Johnson & Johnson Recent Development 11.10 Cipla Limited 11.10.1 Cipla Limited Company Detail 11.10.2 Cipla Limited Business Overview 11.10.3 Cipla Limited HIV Therapeutics Introduction 11.10.4 Cipla Limited Revenue in HIV Therapeutics Business (2017-2022) 11.10.5 Cipla Limited Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global HIV Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Table 3. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Table 4. Key Players of Entry and Fusion Inhibitors Table 5. Key Players of Protease Inhibitors (PIs) Table 6. Key Players of Integrase Inhibitors Table 7. Key Players of Coreceptor Antagonists Table 8. Global HIV Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global HIV Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 10. Global HIV Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 11. Global HIV Therapeutics Market Share by Region (2017-2022) Table 12. Global HIV Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 13. Global HIV Therapeutics Market Share by Region (2023-2028) Table 14. HIV Therapeutics Market Trends Table 15. HIV Therapeutics Market Drivers Table 16. HIV Therapeutics Market Challenges Table 17. HIV Therapeutics Market Restraints Table 18. Global HIV Therapeutics Revenue by Players (2017-2022) & (US$ Million) Table 19. Global HIV Therapeutics Market Share by Players (2017-2022) Table 20. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2021) Table 21. Ranking of Global Top HIV Therapeutics Companies by Revenue (US$ Million) in 2021 Table 22. Global 5 Largest Players Market Share by HIV Therapeutics Revenue (CR5 and HHI) & (2017-2022) Table 23. Key Players Headquarters and Area Served Table 24. Key Players HIV Therapeutics Product Solution and Service Table 25. Date of Enter into HIV Therapeutics Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global HIV Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 28. Global HIV Therapeutics Revenue Market Share by Type (2017-2022) Table 29. Global HIV Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 30. Global HIV Therapeutics Revenue Market Share by Type (2023-2028) Table 31. Global HIV Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 32. Global HIV Therapeutics Revenue Market Share by Application (2017-2022) Table 33. Global HIV Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 34. Global HIV Therapeutics Revenue Market Share by Application (2023-2028) Table 35. North America HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 36. North America HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 38. Europe HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 39. Asia-Pacific HIV Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 40. Asia-Pacific HIV Therapeutics Market Size by Region (2023-2028) & (US$ Million) Table 41. Latin America HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 42. Latin America HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 43. Middle East & Africa HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 44. Middle East & Africa HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 45. Boehringer Ingelheim International GmbH Company Detail Table 46. Boehringer Ingelheim International GmbH Business Overview Table 47. Boehringer Ingelheim International GmbH HIV Therapeutics Product Table 48. Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million) Table 49. Boehringer Ingelheim International GmbH Recent Development Table 50. Merck & Co. Company Detail Table 51. Merck & Co. Business Overview Table 52. Merck & Co. HIV Therapeutics Product Table 53. Merck & Co. Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million) Table 54. Merck & Co. Recent Development Table 55. ViiV Healthcare Company Detail Table 56. ViiV Healthcare Business Overview Table 57. ViiV Healthcare HIV Therapeutics Product Table 58. ViiV Healthcare Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million) Table 59. ViiV Healthcare Recent Development Table 60. AbbVie Company Detail Table 61. AbbVie Business Overview Table 62. AbbVie HIV Therapeutics Product Table 63. AbbVie Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million) Table 64. AbbVie Recent Development Table 65. F. Hoffmann-La Roche Ltd. Company Detail Table 66. F. Hoffmann-La Roche Ltd. Business Overview Table 67. F. Hoffmann-La Roche Ltd. HIV Therapeutics Product Table 68. F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million) Table 69. F. Hoffmann-La Roche Ltd. Recent Development Table 70. Teva Pharmaceutical Industries Ltd. Company Detail Table 71. Teva Pharmaceutical Industries Ltd. Business Overview Table 72. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Product Table 73. Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million) Table 74. Teva Pharmaceutical Industries Ltd. Recent Development Table 75. Bristol-Myers Squibb Company Detail Table 76. Bristol-Myers Squibb Business Overview Table 77. Bristol-Myers Squibb HIV Therapeutics Product Table 78. Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million) Table 79. Bristol-Myers Squibb Recent Development Table 80. Gilead Sciences Company Detail Table 81. Gilead Sciences Business Overview Table 82. Gilead Sciences HIV Therapeutics Product Table 83. Gilead Sciences Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million) Table 84. Gilead Sciences Recent Development Table 85. Johnson & Johnson Company Detail Table 86. Johnson & Johnson Business Overview Table 87. Johnson & Johnson HIV Therapeutics Product Table 88. Johnson & Johnson Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million) Table 89. Johnson & Johnson Recent Development Table 90. Cipla Limited Company Detail Table 91. Cipla Limited Business Overview Table 92. Cipla Limited HIV Therapeutics Product Table 93. Cipla Limited Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million) Table 94. Cipla Limited Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Global HIV Therapeutics Market Share by Type: 2021 VS 2028 Figure 2. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Features Figure 3. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features Figure 4. Entry and Fusion Inhibitors Features Figure 5. Protease Inhibitors (PIs) Features Figure 6. Integrase Inhibitors Features Figure 7. Coreceptor Antagonists Features Figure 8. Global HIV Therapeutics Market Share by Application in 2021 & 2028 Figure 9. Hospitals Case Studies Figure 10. Clinics Case Studies Figure 11. Labs Case Studies Figure 12. HIV Therapeutics Report Years Considered Figure 13. Global HIV Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global HIV Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global HIV Therapeutics Market Share by Region: 2021 VS 2028 Figure 16. Global HIV Therapeutics Market Share by Players in 2021 Figure 17. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2021) Figure 18. The Top 10 and 5 Players Market Share by HIV Therapeutics Revenue in 2021 Figure 19. North America HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. North America HIV Therapeutics Market Share by Country (2017-2028) Figure 21. United States HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe HIV Therapeutics Market Share by Country (2017-2028) Figure 25. Germany HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific HIV Therapeutics Market Share by Region (2017-2028) Figure 33. China HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Japan HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. South Korea HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Southeast Asia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. India HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Australia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America HIV Therapeutics Market Share by Country (2017-2028) Figure 41. Mexico HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Brazil HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Middle East & Africa HIV Therapeutics Market Share by Country (2017-2028) Figure 45. Turkey HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Saudi Arabia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Boehringer Ingelheim International GmbH Revenue Growth Rate in HIV Therapeutics Business (2017-2022) Figure 48. Merck & Co. Revenue Growth Rate in HIV Therapeutics Business (2017-2022) Figure 49. ViiV Healthcare Revenue Growth Rate in HIV Therapeutics Business (2017-2022) Figure 50. AbbVie Revenue Growth Rate in HIV Therapeutics Business (2017-2022) Figure 51. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in HIV Therapeutics Business (2017-2022) Figure 52. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in HIV Therapeutics Business (2017-2022) Figure 53. Bristol-Myers Squibb Revenue Growth Rate in HIV Therapeutics Business (2017-2022) Figure 54. Gilead Sciences Revenue Growth Rate in HIV Therapeutics Business (2017-2022) Figure 55. Johnson & Johnson Revenue Growth Rate in HIV Therapeutics Business (2017-2022) Figure 56. Cipla Limited Revenue Growth Rate in HIV Therapeutics Business (2017-2022) Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Boehringer Ingelheim International GmbH Merck & Co. ViiV Healthcare AbbVie F. Hoffmann-La Roche Ltd. Teva Pharmaceutical Industries Ltd. Bristol-Myers Squibb Gilead Sciences Johnson & Johnson Cipla Limited